RecruitingNot ApplicableNCT05914779

Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)


Sponsor

Hamad Medical Corporation

Enrollment

1,000 participants

Start Date

Mar 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Specific Aim : The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment. Hypothesis a: 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b: There will be no difference in subsequent incidence of proven infections in the no antibiotics vs, early antibiotics groups Hypothesis c: There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs. no antibiotics groups


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No use of antibiotics and with antibiotics treatment for people with infection, bacterial and out-of-hospital cardiac arrest. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo use of antibiotics

Subjects will be randomized into antibiotics and no antibiotics groups based on inclusion and exclusion criteria

OTHERwith antibiotics treatment

with antibiotics treatment


Locations(1)

Hamad Medical Corporation

Doha, Baladiyat ad Dawhah, Qatar

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05914779


Related Trials